Association of IL8 polymorphisms with overall survival in patients with renal cell carcinoma in COMPARZ (pazopanib versus sunitinib phase III study)

被引:0
|
作者
Xu, Chun-Fang
Johnson, Toby
Choueiri, Toni K.
Deen, Keith C.
Xue, Zhengyu
Spraggs, Colin F.
Bartlett-Pandite, Arundathy N.
Carpenter, Christopher
Motzer, Robert John
机构
[1] GlaxoSmithKline, Harlow, Essex, England
[2] GlaxoSmithKline, Uxbridge, Middx, England
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] GlaxoSmithKline, Collegeville, PA USA
[5] GlaxoSmithKline, Res Triangle Pk, NC USA
[6] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4519
引用
收藏
页数:1
相关论文
共 50 条
  • [1] IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    Xu, C-F
    Johnson, T.
    Garcia-Donas, J.
    Choueiri, T. K.
    Sternberg, C. N.
    Davis, I. D.
    Bing, N.
    Deen, K. C.
    Xue, Z.
    McCann, L.
    Esteban, E.
    Whittaker, J. C.
    Spraggs, C. F.
    Rodriguez-Antona, C.
    Pandite, L. N.
    Motzer, R. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (07) : 1190 - 1198
  • [2] IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    C-F Xu
    T Johnson
    J Garcia-Donas
    T K Choueiri
    C N Sternberg
    I D Davis
    N Bing
    K C Deen
    Z Xue
    L McCann
    E Esteban
    J C Whittaker
    C F Spraggs
    C Rodríguez-Antona
    L N Pandite
    R J Motzer
    British Journal of Cancer, 2015, 112 : 1190 - 1198
  • [3] Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
    Motzer, Robert J.
    Hutson, Thomas E.
    McCann, Lauren
    Deen, Keith
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (18): : 1769 - 1770
  • [4] Quality of life (QoL) among patients with renal cell carcinoma (RCC) treated with pazopanib versus sunitinib in the COMPARZ study
    Cella, David
    Hackshaw, Michelle Denise
    Diaz, Jose
    Huang, Chun
    Deen, Keith C.
    Crescenzo, Rocco
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
    Meta H. M. Diekstra
    Xiaoyan Liu
    Jesse J. Swen
    Epie Boven
    Daniel Castellano
    Hans Gelderblom
    Ron H. J. Mathijssen
    Cristina Rodríguez-Antona
    Jesus García-Donas
    Brian I. Rini
    Henk-Jan Guchelaar
    European Journal of Clinical Pharmacology, 2015, 71 : 1477 - 1484
  • [6] Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
    Diekstra, Meta H. M.
    Liu, Xiaoyan
    Swen, Jesse J.
    Boven, Epie
    Castellano, Daniel
    Gelderblom, Hans
    Mathijssen, Ron H. J.
    Rodriguez-Antona, Cristina
    Garcia-Donas, Jesus
    Rini, Brian I.
    Guchelaar, Henk-Jan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) : 1477 - 1484
  • [7] ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN IL8 AND IL13 WITH SUNITINIB-INDUCED TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA.
    Liu, X.
    Diekstra, M. H.
    Swen, J. J.
    Boven, E.
    Castellano, D.
    Gelderblom, H.
    Mathijssen, R. H.
    Rodriguez-Antona, C.
    Garcia-Donas, J.
    Rini, B. I.
    Guchelaar, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S84 - S84
  • [8] ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN IL8 AND IL13 WITH SUNITINIB-INDUCED TOXICITY IN PATIENTS WITHMETASTATIC RENAL CELL CARCINOMA.
    Liu, X.
    Diekstra, M. H.
    Swen, J. J.
    Boven, E.
    Castellano, D.
    Gelderblom, H.
    Mathijssen, R. H.
    Rodriguez-Antona, C.
    Garcia-Donas, J.
    Rini, B. I.
    Guchelaar, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S6 - S7
  • [9] Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies
    Xinan Sheng
    Jie Jin
    Zhisong He
    Yiran Huang
    Aiping Zhou
    Jinwan Wang
    Xiubao Ren
    Dingwei Ye
    Xu Zhang
    Shukui Qin
    Fangjian Zhou
    Binhui Wang
    Jun Guo
    BMC Cancer, 20
  • [10] Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies
    Sheng, Xinan
    Jin, Jie
    He, Zhisong
    Huang, Yiran
    Zhou, Aiping
    Wang, Jinwan
    Ren, Xiubao
    Ye, Dingwei
    Zhang, Xu
    Qin, Shukui
    Zhou, Fangjian
    Wang, Binhui
    Guo, Jun
    BMC CANCER, 2020, 20 (01)